ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage

Cell Cycle

Volumn 12, Issue 4, 2013, Pages 698-704

  Moumen, Abdeladim ^a,c   Magill, Christine ^b   Dry, Katherine L ^b   Jackson, Stephen P ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Moroccan Foundation for Advanced Science   (Morocco)

Author keywords

ATM; DNA damage; P53; Phosphorylation; Transcription

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; PROTEIN P53; SMALL INTERFERING RNA; WORTMANNIN;

ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; IONIZING RADIATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TARGETING; TRANSCRIPTION INITIATION;

EID: 84874586389     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23592     Document Type: Article

References (29)

1. Matunis MJ, Michael WM, Dreyfuss G. Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol Cell Biol 1992; 12:164-71; PMID:1729596
2. Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays 2004; 26:629-38; PMID:15170860; http://dx.doi.org/10.1002/ bies.20048
3. Bomsztyk K, Van Seuningen I, Suzuki H, Denisenko O, Ostrowski J. Diverse molecular interactions of the hnRNP K protein. FEBS Lett 1997; 403:113-5; PMID:9042948; http://dx.doi.org/10.1016/S0014-5793(97)00041-0
4. Tomonaga T, Levens D. Activating transcription from single stranded DNA. Proc Natl Acad Sci U S A 1996; 93:5830-5; PMID:8650178; http://dx.doi.org/10. 1073/pnas.93.12.5830
5. Tomonaga T, Levens D. Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator. J Biol Chem 1995; 270:4875-81; PMID:7876260; http://dx.doi.org/10.1074/jbc.270.9.4875
6. Ostrowski J, Kawata Y, Schullery DS, Denisenko ON, Higaki Y, Abrass CK, et al. Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA. Proc Natl Acad Sci U S A 2001; 98:9044-9; PMID:11470915; http://dx.doi.org/10.1073/pnas.161284098
7. Van Seuningen I, Ostrowski J, Bustelo XR, Sleath PR, Bomsztyk K. The K protein domain that recruits the interleukin 1-responsive K protein kinase lies adjacent to a cluster of c-Src and Vav SH3-binding sites. Implications that K protein acts as a docking platform. J Biol Chem 1995; 270:26976-85; PMID:7592945; http://dx.doi.org/10.1074/jbc.270.45.26976
8. Mikula M, Karczmarski J, Dzwonek A, Rubel T, Hennig E, Dadlez M, et al. Casein kinases phosphorylate multiple residues spanning the entire hnRNP K length. Biochim Biophys Acta 2006; 1764:299-306; PMID:16448870; http://dx.doi.org/10.1016/j.bbapap.2005.12.004
9. Ostareck-Lederer A, Ostareck DH, Cans C, Neubauer G, Bomsztyk K, Superti-Furga G, et al. c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol 2002; 22:4535-43; PMID:12052863; http://dx.doi. org/10.1128/MCB.22.13.4535-4543.2002
10. Schullery DS, Ostrowski J, Denisenko ON, Stempka L, Shnyreva M, Suzuki H, et al. Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein. J Biol Chem 1999; 274:15101-9; PMID:10329716; http://dx.doi. org/10.1074/jbc.274.21.15101
11. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28:739-45; PMID:18082599; http://dx.doi.org/10.1016/j.molcel. 2007.11.015
12. Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002; 297:547-51; PMID:12142523; http://dx.doi. org/10.1126/science.1074740
13. Jackson SP, Bartek J. The DNA damage response in human biology and disease. Nature 2009; 461:1071-8; PMID:19847258; http://dx.doi.org/10.1038/ nature08467
14. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19:238-45; PMID:17303408; http://dx.doi.org/10.1016/j.ceb.2007.02.009
15. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3:155-68; PMID:12612651; http://dx.doi.org/10.1038/nrc1011
16. Moumen A, Masterson P, O'Connor MJ, Jackson SP. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 2005; 123:1065-78; PMID:16360036; http://dx.doi. org/10.1016/j.cell.2005.09.032
17. Enge M, Bao W, Hedström E, Jackson SP, Moumen A, Selivanova G. MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53. Cancer Cell 2009; 15:171-83; PMID:19249676; http://dx.doi.org/10.1016/j. ccr.2009.01.019
18. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 2004; 64:9152-9; PMID:15604286; http://dx.doi. org/10.1158/0008-5472.CAN-04-2727
19. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992; 256:827-30; PMID:1589764; http://dx.doi. org/10.1126/science.1589764
20. Chen Y, Zhou X, Liu N, Wang C, Zhang L, Mo W, et al. Arginine methylation of hnRNP K enhances p53 transcriptional activity. FEBS Lett 2008; 582:1761-5; PMID:18472002; http://dx.doi.org/10.1016/j.febslet. 2008.04.051
21. Pelisch F, Pozzi B, Risso G, Muñoz MJ, Srebrow A. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J Biol Chem 2012; 287:30789-99; PMID:22825850; http://dx.doi.org/10.1074/jbc. M112.390120
22. Pereg Y, Shkedy D, de Graaf P, Meulmeester E, Edelson-Averbukh M, Salek M, et al. Phosphorylation of Hdmx mediates its Hdm2-and ATM-dependent degradation in response to DNA damage. Proc Natl Acad Sci U S A 2005; 102:5056-61; PMID:15788536; http://dx.doi.org/10.1073/pnas.0408595102
23. Hsueh KW, Fu SL, Huang CY, Lin CH. Aurora A phosphorylates hnRNPK and disrupts its interaction with p53. FEBS Lett 2011; 585:2671-5; PMID:21821029; http://dx.doi.org/10.1016/j.febslet.2011.07.031
24. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142:409-19; PMID:20673990; http://dx.doi.org/10.1016/j. cell.2010.06.040
25. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989
26. Biton S, Dar I, Mittelman L, Pereg Y, Barzilai A, Shiloh Y. Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. J Biol Chem 2006; 281:17482-91; PMID:16627474; http://dx.doi. org/10.1074/jbc.M601895200
27. Espinosa JM, Verdun RE, Emerson BM. p53 functions through stress-and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 2003; 12:1015-27; PMID:14580351; http://dx.doi.org/ 10.1016/S1097-2765(03)00359-9
28. Zeng SX, Dai MS, Keller DM, Lu H. SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J 2002; 21:5487-97; PMID:12374749; http://dx.doi.org/10.1093/emboj/cdf540
29. McKinney K, Mattia M, Gottifredi V, Prives C. p53 linear diffusion along DNA requires its C terminus. Mol Cell 2004; 16:413-24; PMID:15525514; http://dx.doi.org/10.1016/j.molcel.2004.09.032